Abstract
Early diagnosis and early initiation of adequate therapy in the spectrum of anxiety disorders (AD) is one of the pressing problems of modern medicine, which is determined by the high prevalence and significant impact on quality of life of AD is not only burdened with somatic patients, but also physically healthy people. The article deals with aspects of diagnosis and treatment of TS in the general medical network, in particular, describes the currently recommended regimen of the drug Phenorelaxan and benefits of this drug.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
